Depreciation of InMed Pharmaceuticals Inc. from 30 Sep 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
InMed Pharmaceuticals Inc. quarterly and annual Depreciation in USD history and change rate from 30 Sep 2019 to 30 Jun 2025.
  • InMed Pharmaceuticals Inc. Depreciation for the quarter ending 30 Jun 2025 was $12,206, a 124% increase year-over-year.
  • InMed Pharmaceuticals Inc. Depreciation for the twelve months ending 30 Jun 2025 was $50,204, a 5.2% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Depreciation for 2025 was $50,204, a 5.2% increase from 2024.
  • InMed Pharmaceuticals Inc. annual Depreciation for 2024 was $47,742, a 21% increase from 2023.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

InMed Pharmaceuticals Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $50,204 $12,206 +$6,765 +124% 01 Apr 2025 30 Jun 2025 10-K 23 Sep 2025 2025 FY
Q1 2025 $43,439 $12,203 -$2,017 -14% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q3
Q4 2024 $45,456 $12,209 -$2,033 -14% 01 Oct 2024 31 Dec 2024 10-Q 12 Feb 2025 2025 Q2
Q3 2024 $47,489 $13,586 -$253 -1.8% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $47,742 $5,441 01 Apr 2024 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q1 2024 $14,220 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q3
Q4 2023 $14,242 +$6,186 +77% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025 2025 Q2
Q3 2023 $13,839 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q4 2022 $8,056 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024 2024 Q2
Q3 2020 $21,351 +$14,171 +197% 01 Jul 2020 30 Sep 2020 10-Q 17 Dec 2020 2021 Q1
Q3 2019 $7,180 01 Jul 2019 30 Sep 2019 10-Q 17 Dec 2020 2021 Q1

InMed Pharmaceuticals Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $50,204 +$2,462 +5.2% 01 Jul 2024 30 Jun 2025 10-K 23 Sep 2025 2025 FY
2024 $47,742 +$8,129 +21% 01 Jul 2023 30 Jun 2024 10-K 23 Sep 2025 2025 FY
2023 $39,613 01 Jul 2022 30 Jun 2023 10-K 30 Sep 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.